The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) provides a framework for the diagnosis of neurocognitive disorders based on three syndromes: delirium, mild neurocognitive disorder and major neurocognitive disorder
Major neurocognitive disorder is mostly synonymous with dementia, although the criteria have been modified so that impairments in learning and memory are not necessary for diagnosis
DSM-5 describes criteria to delineate specific aetiological subtypes of mild and major neurocognitive disorder
The diagnostic certainty of an aetiological diagnosis is based on clinical features and biomarkers, and can be qualified as probable or possible
The DSM-5 criteria are consistent with those developed by various expert groups for the different aetiological subtypes of neurocognitive disorders
Further validation in clinical practice is necessary, but we expect these criteria will have high reliability and validity, and widespread adoption will bring consistency to the diagnosis of diverse neurocognitive disorders
Neurocognitive disorders—including delirium, mild cognitive impairment and dementia—are characterized by decline from a previously attained level of cognitive functioning. These disorders have diverse clinical characteristics and aetiologies, with Alzheimer disease, cerebrovascular disease, Lewy body disease, frontotemporal degeneration, traumatic brain injury, infections, and alcohol abuse representing common causes. This diversity is reflected by the variety of approaches to classifying these disorders, with separate groups determining criteria for each disorder on the basis of aetiology. As a result, there is now an array of terms to describe cognitive syndromes, various definitions for the same syndrome, and often multiple criteria to determine a specific aetiology. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) provides a common framework for the diagnosis of neurocognitive disorders, first by describing the main cognitive syndromes, and then defining criteria to delineate specific aetiological subtypes of mild and major neurocognitive disorders. The DSM-5 approach builds on the expectation that clinicians and research groups will welcome a common language to deal with the neurocognitive disorders. As the use of these criteria becomes more widespread, a common international classification for these disorders could emerge for the first time, thus promoting efficient communication among clinicians and researchers.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 1st edn (American Psychiatric Association, 1952).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn (American Psychiatric Association, 1994).
Prince, M. et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63–75 (2013).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).
Ganguli, M. et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am. J. Geriatr. Psychiatry 19, 205–210 (2011).
Sachdev, P. S. Is DSM-5 defensible? Aust. N. Z. J. Psychiatry 47, 10–11 (2013).
Sternberg, R. J. & Sternberg, K. Cognitive Psychology 6th edn (Cengage Learning, 2009).
Sachdev, P., Andrews, G., Hobbs, M. J., Sunderland, M. & Anderson, T. M. Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11. Psychol. Med. 39, 2001–2012 (2009).
Mesulam, M.-M. (Ed.). Principles of Behavioral and Cognitive Neurology 2nd edn (Oxford University Press, 2000).
Lezak, M. D., Howieson, D. B. & Loring, D. W. Neuropsychological Assessment 4th edn (Oxford University Press, 2004).
Joshi, A. et al. “What's in a name?” Delirium by any other name would be as deadly. A review of the nature of delirium consultations. J. Psychiatr. Pract. 18, 413–418 (2012).
Petersen, R. et al. Mild cognitive impairment: ten years later. Arch. Neurology 66, 1447–1455 (2009).
Sachdev, P. Is it time to retire the term “dementia”? J. Neuropsychiatry Clin. Neurosci. 12, 276–279 (2000).
Looi, J. C. & Sachdev, P. S. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 53, 670–678 (1999).
Josephs, K. A. Frontotemporal dementia and related disorders: deciphering the enigma. Ann. Neurol. 64, 4–14 (2008).
Blazer, D. Neurocognitive disorders in DSM-5. Am. J. Psychiatry 170, 585–587 (2013).
Petersen, R. C. et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303–308 (1999).
Winblad, B. et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256, 240–246 (2004).
Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183–194 (2004).
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270–279 (2011).
Ganguli, M. Can the DSM-5 framework enhance the diagnosis of MCI? Neurology 81, 2045–2050 (2013).
Rabins, P. V. & Lyketsos, C. G. A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am. J. Geriatr. Psychiatry 19, 201–204 (2011).
Dubois, B. et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria. Lancet Neurol. 6, 734–746 (2007).
McKhann, G. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939–944 (1984).
Román, G. C. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop. Neurology 43, 250–260 (1993).
Hughes, T. F., Snitz, B. E. & Ganguli, M. Should mild cognitive impairment be subtyped? Curr. Opin. Psychiatry 24, 237–242 (2011).
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 263–269 (2011).
Gorno-Tempini, M. L. et al. Classification of primary progressive aphasia and its variants. Neurology 76, 1006–1014 (2011).
Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456–2477 (2011).
McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65, 1863–1872 (2005).
Sachdev, P. S. et al. Diagnostic criteria for vascular cognitive disorder: a VASCOG statement. Alzheimer Dis. Assoc. Disord. 28, 208–218 (2014).
Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22, 1689–1707 (2007).
Antinori, A. et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 1789–1799 (2007).
Gorelick, P. B. et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672–2713 (2011).
The authors would like to thank Prof. Igor Grant, the members of the DSM-5 Task Force and the other Work Groups, as well as many external advisers and consultants who provided invaluable input to the development of the classification. M.G. was supported in part by the National Institute on Aging, the National Institutes of Health, and the Department of Health and Human Services, USA (grant K07 AG044395). D.V.J. was supported in part by the National Institute of Mental Health, USA (grant R01 MH099987), and by the Sam and Rose Stein Institute for Research on Aging. P.S. was supported in part by the National Health and Medical Research Council of Australia (grant 568969).
The authors were members of the Neurocognitive Disorders Work Group for DSM-5. D.V.J. was President of the American Psychiatric Association from 2012–2013 when DSM-5 was published.
About this article
Cite this article
Sachdev, P., Blacker, D., Blazer, D. et al. Classifying neurocognitive disorders: the DSM-5 approach. Nat Rev Neurol 10, 634–642 (2014). https://doi.org/10.1038/nrneurol.2014.181
Clinically accessible neuroimaging predictors of post-stroke neurocognitive disorder: a prospective observational study
BMC Neurology (2021)
BMC Nephrology (2021)
The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population
Scientific Reports (2021)
Innovative motor and cognitive dual-task approaches combining upper and lower limbs may improve dementia early detection
Scientific Reports (2021)
Assessing Neuropsychological Functions in Middle Childhood: a Narrative Review of Measures and Their Psychometric Properties Across Context
Journal of Pediatric Neuropsychology (2021)